## Abstract ## BACKGROUND: This study aimed to determine the potential diagnostic value of migration‐inhibitory factor (MIF) for gastric cancer in patients presenting with dyspepsia and its prognostic value for gastric cancer. ## METHODS: A cohort of 97 patients with histologically confirmed gas
Serum glycoproteins and HLA types as a prognostic marker and individualization of treatment for gastric cancer
✍ Scribed by K. Ogoshi; T. Mitomi; Y. Kondoh; K. Iwata
- Publisher
- Elsevier Science
- Year
- 1988
- Tongue
- English
- Weight
- 74 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0192-0561
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract We previously reported that a combination of serum hepatocyte growth factor (HGF) and carcinoembryonic antigen (CEA) was useful for selecting early‐stage colorectal cancer patients with aggressive disease. The aim of the present study was to determine whether serum HGF could provide CEA
## Abstract The EGF/IGF growth factors are potent mitogens that regulate cell proliferation and cell survival and are involved in prostate cancer development. Using laser microdissection technology and real‐time PCR, together with immunohistochemistry, we have explored the growth factor and integri
This study was conducted to evaluate the clinical usefulness of serum hCG in the diagnosis and prognosis of patients (n ؍ 59) with cancers of the oral cavity and oropharynx. As a reference marker we used squamous-cell carcinoma antigen (SCCAg). A blood sample was obtained from all patients before
## Abstract S100A2, a calcium‐binding protein, recently became of major interest because of its differential expression during transformation and metastasis in various tumors. The purpose of this study was to investigate the prognostic significance of S100A2 expression in the early‐stage non small